Back to top

CareDx Upgraded on Strong MolDx Reimbursement Decision as Massaro Lifts Price Target from $28 to $45

Analyst Mark Massaro of BTIG reiterated a Buy rating on CareDx, boosting the price target to $45.00. Mark Massaro has given his Buy rating due to a...

Read full article here »

In-Depth Zacks Research for the Tickers Above

Normally $25 each - click below to receive one report FREE:

CareDx, Inc. (CDNA)